Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Role of antiplatelet therapy in cardiovascular disease I: Acute coronary syndromes.

Cavendish JJ, Fugit RV, Safani M.

Curr Med Res Opin. 2004 Nov;20(11):1839-43.

PMID:
15537484
2.

Evidence-based medical therapy of patients with acute coronary syndromes.

Ramanath VS, Eagle KA.

Am J Cardiovasc Drugs. 2007;7(2):95-116. Review.

PMID:
17503881
3.

Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events).

Lim MJ, Eagle KA, Gore JM, Anderson FA Jr, Dabbous OH, Mehta RH, Granger CB, Fox KA, Spencer FA, Goldberg RJ; Global Registry of Acute Coronary Events Investigators..

Am J Cardiol. 2005 Oct 1;96(7):917-21.

PMID:
16188516
4.

API expert consensus document on management of ischemic heart disease.

Association of Physicians of India..

J Assoc Physicians India. 2006 Jun;54:469-80. Review.

PMID:
16909697
5.

[Antiplatelet therapy in acute coronary syndromes without ST segment elevation].

Umman B.

Anadolu Kardiyol Derg. 2006 Apr;6 Suppl 1:13-9. Review. Turkish.

6.

Thrombolytic, antithrombin, and antiplatelet treatment of acute coronary syndromes.

Puma JA, Sketch MH Jr.

J Am Osteopath Assoc. 2000 Nov;100(11 Suppl):S8-12. Review.

PMID:
11191119
7.

Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).

Bromberg-Marin G, Marin-Neto JA, Parsons LS, Canto JG, Rogers WJ; National Registry of Myocardial Infarction-4..

Am J Cardiol. 2006 Nov 1;98(9):1125-31. Epub 2006 Aug 31.

PMID:
17056312
8.

Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland.

Poloński L, Gasior M, Gierlotka M, Kalarus Z, Cieśliński A, Dubiel JS, Gil RJ, Ruzyłło W, Trusz-Gluza M, Zembala M, Opolski G.

Kardiol Pol. 2007 Aug;65(8):861-72; discussion 873-4.

9.

Clinical use of clopidogrel in acute coronary syndrome.

Zambahari R, Kwok OH, Javier S, Mak KH, Piyamitr S, Tri Ho HQ, Hwang JJ, Suryawan R, Chow WH.

Int J Clin Pract. 2007 Mar;61(3):473-81. Review.

10.

Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.

Mehta RH, Greenbaum AB, Lokhnygina Y, Newby LK, Van De Werf F, Armstrong PW, Pieper KS, Califf RM, Granger CB, Harrington RA.

J Interv Cardiol. 2007 Oct;20(5):299-306.

PMID:
17880325
11.

[Two year follow-up of acute ischemic syndrome without ST elevation].

Tan HQ, Zhu J, Liang Y, Zhang Y, Liu LS; Chinese Coordinating Center of OASIS Registry..

Zhonghua Yi Xue Za Zhi. 2005 Jan 19;85(3):184-8. Chinese.

PMID:
15854465
12.
13.

[Antithrombotic therapy for non-ST segment elevation myocardial infarction].

Hölschermann H.

Hamostaseologie. 2006 May;26(2):106-13. Review. German.

PMID:
16676052
14.

Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.

Lim MJ, Spencer FA, Gore JM, Dabbous OH, Agnelli G, Kline-Rogers EM, Dibenedetto D, Eagle KA, Mehta RH; GRACE Investigators..

Eur Heart J. 2005 Jun;26(11):1063-9. Epub 2005 Feb 16.

PMID:
15716281
15.

Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.

Vermeer NS, Bajorek BV.

J Clin Pharm Ther. 2008 Dec;33(6):591-601. doi: 10.1111/j.1365-2710.2008.00950.x.

PMID:
19138236
16.

Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge.

Tricoci P, Roe MT, Mulgund J, Newby LK, Smith SC Jr, Pollack CV Jr, Fintel DJ, Cannon CP, Bhatt DL, Gibler WB, Ohman EM, Peterson ED, Harrington RA.

Arch Intern Med. 2006 Apr 10;166(7):806-11.

PMID:
16606819
17.

Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).

Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J, Weerakkody G, Winters KJ, Warmke JW, McCabe CH, Braunwald E; TRITON-TIMI 38 Investigators..

Am Heart J. 2006 Oct;152(4):627-35.

PMID:
16996826
18.

The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.

Toth PP.

Postgrad Med. 2009 Jan;121(1):59-72. doi: 10.3810/pgm.2009.01.1955. Review.

PMID:
19179814
19.

Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.

Robinson M, Palmer S, Sculpher M, Philips Z, Ginnelly L, Bowens A, Golder S, Alfakih K, Bakhai A, Packham C, Cooper N, Abrams K, Eastwood A, Pearman A, Flather M, Gray D, Hall A.

Health Technol Assess. 2005 Jul;9(27):iii-iv, ix-xi, 1-158. Review.

Supplemental Content

Support Center